Genomic Health, Inc. (GHDX) Tops Q3 EPS by 6c, Sales Fall Inline
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Join SI Premium – FREE
Genomic Health, Inc. (NASDAQ: GHDX) reported Q3 EPS of $0.10, $0.06 better than the analyst estimate of $0.04. Revenue for the quarter came in at $52.1 million versus the consensus estimate of $52.3 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
